1 day ago · Urges Congress to support rare disease patients & support the bill WASHINGTON, D.C. (February 5, 2025) – John F. Crowley, President & CEO of the Biotechnology Innovation Organization (BIO), today released the following statement after introduction of the ORPHAN Cures Act (H.R. 946), a bipartisan bill that removes barriers to treating and curing rare disease: “For more than 40 years, the ...